News wrap-up: This week's headlines, plus a new cancer screening test
Check out this week’s top headlines.
perfectlab/stock.adobe.com
As we enter the holiday season, we want to continue to keep you updated with the latest pandemic news and coverage of the veterinary industry.
Here's a look at this week’s news highlights:
- The US Food and Drug Administration (FDA) announced last month the approval of Stelfonta (tigilanol tiglate injection), the first intratumoral injection to treat nonmetastatic cutaneous mast cell tumors (MCTs) in dogs.
- VolitionRX Limited (through its subsidiary Volition Veterinary Diagnostics Development LLC) released the Nu.Q Vet Cancer Screening Test. This enzyme-linked immunosorbent assay (ELISA)–based test is noninvasive, inexpensive, and easy to use.
- A spirited boxer named Chopper won the “Most Unusual Pet Insurance Claim of the Year” at the 12th annual Hambone Awards, presented by Nationwide.
- This week, we were excited to announce that we are hosting several live free webinars this month.
Recent Videos
Related Content
Size of Phoenix pharmacy compounding facility has nearly doubled
December 11th 2024Article
Covetrus announced the expansion of its' site in Arizona, increasing the company’s pharmacy capabilities for producing compounded products for use in veterinary clinics and pet owners' homes throughout the US
Read More
